Global Autoimmune Disease Diagnostics Market by Type (Localized Autoimmune Disease Diagnostics Disease Diagnostics, Systemic Autoimmune Disease Diagnostics) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Industry Insights

Global autoimmune disease diagnostics market was valued at USD 3.33 billion in 2015, and is expected to grow at a CAGR of 4.1% by 2025 to USD 5.0 billion. The key driver of growth is the rising prevalence of autoimmune diseases such as type 1 diabetes among newborn babies, and the demand for quick diagnostics.

Due to rising incidence of autoimmune diseases and consequent increase in healthcare costs, research and diagnostics centers around the world are taking steps to comply with government agencies. These disorders are ranked among the top ten leading causes of increased mortality in women, according to data from the National Institutes of Health.

U.S. market for autoimmune disease diagnostics, type 2013-2025 (USD billion)

Market growth is expected to be driven by technological advances and increased lab automation rates. Advanced technology is being used by clinicians to perform multiple tests simultaneously with more accurate results and faster.

The slow turnaround time for conventional diagnostic methods and the lack of standard tests for more than 80 diseases are two of the reasons that laboratories should move towards automation.

Market dynamics will be boosted by the expected positive impact of government initiatives. Patients and healthcare professionals can be educated by organizations such as the Autoimmunity Centers of Excellence and Cooperative Study Group for Autoimmune Disease Prevention and North American Rheumatoid Arthritis Consortium.

The market is expected to grow as patients become more aware of these diseases. The American Autoimmune Related Diseases Association, Inc. (AARDA), conducted a survey in 2013 that showed that American patients were able to identify autoimmune diseases by 10% more than the previous survey.

This can be attributed in part to the extensive public awareness campaigns, such as the Autoimmune Awareness Month (March 2014) and the National Awareness Campaign (AARDA).

Type Insights

Acute autoimmune diseases can be divided into two types based on their type: localized and systemic.

In 2015, the market was dominated by localized disease diagnosis. Its large market share is due to large procedures volumes and a higher level of patient awareness (compared with systemic diseases).

However, systemic disease diagnostics will see the greatest growth due to the implementation of favorable government policies, including the AMP RA/SLE program that provides treatment for patients with rheumatoid and systemic lupus erythematosus.

It is expected that the program will provide a platform to develop novel therapeutics as well as the creation of precompetitive and disease-specific databases which can be used for further research.

Market for systemic autoimmune diseases diagnostics in the global market by type, 2015.

Regional Insights

North America held the largest market share at over 40% in 2015. This was mainly due to the Affordable Care Act's introduction, favorable regulations and initiatives taken by the AARDA, as well as high levels of disease prevalence in the region.

AARDA estimates that nearly 50 million Americans suffer from an autoimmune disorder. These diseases are extremely common and high healthcare costs have prompted the government to take favorable initiatives. These initiatives are designed to reduce healthcare expenditure by diagnosing early-stage diseases and increasing patient awareness.

Asia Pacific is expected to experience lucrative growth because of the continuous improvement in healthcare infrastructure, patient awareness levels and high unmet medical needs. The forecast period will see an increase in its revenue share. Its market share will increase from 21.0% in 2015, to more than 22.0% by 2025.

Competitive Insights

This market is highly concentrated and is often marked by large mergers and acquisitions. F. Hoffmann-La Roche Ltd., Siemens Healthineers, Abbott Laboratories, Beckman Coulter, Inc., SQI Diagnostics, Quest Diagnostics, EUROIMMUN AG, and AESKU.Diagnostics GmbH. KG. INOVA Diagnostics, Inc., Crescendo Bioscience, Inc., bioMerieux SA, Bio-Rad Laboratories, Inc., and Hemagen Diagnostics, Inc.

Most of the key players are committed to developing novel products that can be used for quick and efficient diagnosis. Inova, for example, announced in 2016 the approval of its QUANTA flash dsDNA, Scl70 and Jo-1 assays for diagnosing systemic lupus erythematosus and systemic sclerosis.

The Report Covers Certain Segments

This report provides an analysis of industry trends and forecasts revenue growth for each sub-segment from 2014 to 2025. Up Market Research segmented the market for autoimmune disease diagnostics on the basis type and region.

• Type Outlook (Revenue USD Million; 2014-2025)

  • Systemic autoimmune disease diagnostics

    • Rheumatoid arthritis

    • Ankylosing Spondylitis

    • Systemic Lupus Erythematosus (SLE)

    • Other

  • Localized autoimmune disease diagnostics

    • Multiple sclerosis

    • Type 1 Diabetes

    • Thyroiditis in Hashimoto

    • Idiopathic thrombocytopenic Purpura

    • Other

• Regional Outlook (Revenue USD Million; 2014-2025)

  • North America

    • The U.S.

    • Canada

  • Europe

    • Germany

    • The U.K.

  • Asia Pacific

    • China

    • Japan

    • India

  • Latin America

    • Mexico

    • Brazil

  • MEA

    • South Africa

Up Market Research published a new report titled “Autoimmune Disease Diagnostics Market research report which is segmented by Type (Localized Autoimmune Disease Diagnostics Disease Diagnostics, Systemic Autoimmune Disease Diagnostics), By Players/Companies F Hoffmann-La Roche Ltd; Siemens Healthineers; Abbott Laboratories; Beckman Coulter, Inc; bioMerieux SA; Bio-Rad Laboratories, Inc; and Hemagen Diagnostics, Inc, Inc; Crescendo Bioscience, Inc; SQI Diagnostics; Quest Diagnostics; EUROIMMUN AG; AESKUDiagnostics GmbH & Co KG; INOVA Diagnostics”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Autoimmune Disease Diagnostics Market Report Segments:

The market is segmented by Type (Localized Autoimmune Disease Diagnostics Disease Diagnostics, Systemic Autoimmune Disease Diagnostics).

Autoimmune Disease Diagnostics Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Autoimmune Disease Diagnostics Market

Overview of the regional outlook of the Autoimmune Disease Diagnostics Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Autoimmune Disease Diagnostics Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Autoimmune Disease Diagnostics Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Localized Autoimmune Disease Diagnostics Disease Diagnostics

                2. Systemic Autoimmune Disease Diagnostics

7. Market scenario by region, sub-region, and country.
8. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
9. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
10. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Autoimmune Disease Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Autoimmune Disease Diagnostics Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.